Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. - Wikidata - wikimedia - TriplyDB

Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

http://www.wikidata.org/entity/Q37494112

about

Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection Cholera toxin: a paradigm of a multifunctional protein A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity Induction of thymus-derived gammadelta T Cells by Escherichia coli enterotoxin b subunit in peritoneal cavities of mice IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE)Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue Mucosal immunity and tolerance: relevance to vaccine development.Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance.Autoantigens plus interleukin-10 suppress diabetes autoimmunity.Immunomodulation using bacterial enterotoxins.Mucosal immunity and vaccines.Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera.Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent.Immunomodulation and vaccination for atherosclerosis.Peptide-based therapeutic vaccines for allergic and autoimmune diseases.A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections.Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function.Delivery systems and adjuvants for oral vaccines.Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin Anti-inflammatory effect of cholera toxin B subunit in experimental stroke.Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.The B subunit of Escherichia coli heat-labile enterotoxin induces both caspase-dependent and -independent cell death pathways in CD8+ T cells The ABC of clinical and experimental adjuvants--a brief overview.Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4.Heat-labile enterotoxins as adjuvants or anti-inflammatory agents.Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we?Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease.Tonsillar application of formalin-killed cells of Streptococcus sobrinus reduces experimental dental caries in rabbits.Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation.The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages.The cholera toxin B subunit directly costimulates antigen-primed CD4+ T cells ex vivo.Cholera toxin and Escherichia coli enterotoxin B-subunits inhibit macrophage-mediated antigen processing and presentation: evidence for antigen persistence in non-acidic recycling endosomal compartments.

P2860

Q24548763-4AF25C1C-47A8-47EA-BC79-08046707F130 Q24598726-A4E933AF-E433-4824-ADA7-65937388AB0C Q27633142-377FE59F-28C3-4E93-90D2-FD687FE3C651 Q28770045-1690DD22-B922-408B-9814-A54F5BB1216D Q33525565-2837A4FE-F6DF-47E6-AD96-F50AD7FF13E3 Q33769366-C70413F1-0F56-4BCD-9DB2-FF55D67E1170 Q33776172-8405CFEE-7529-40EC-AD50-8D8468BA7070 Q33928456-A1BF4900-8C1B-435E-B5FA-6DC1547869A0 Q34008642-7E932FAE-DDBE-42AC-839A-4EA26DDCF5F0 Q34113929-EBEC2980-E760-465D-8412-38122CDF65C0 Q34184898-7A70FDEC-48CC-460A-B0E8-7EE5858D8A4D Q34409172-395A86F9-6921-4360-94F8-5B81DC9F8017 Q34629092-185D241C-8C3E-47C3-BFB6-033CC419496E Q34715639-A5E5C6DB-2910-4A23-8ADF-6BBBDD6BA57A Q34933032-C071126B-BC08-4360-A962-A5233C34B352 Q35098194-59FCA20F-1BAB-4A78-A244-4226DE31AC4B Q35134310-80F73E6C-F094-4A1E-BDC9-AE13ACD9C628 Q35619878-8E7A9D72-B9D9-41DF-9312-8AC101109B44 Q35753555-E8DD6662-5ED8-4CCC-9847-838E123EA646 Q36090197-4D941F67-F6B6-43E4-ADA2-735C411A641B Q36140954-3826F24A-14D2-4477-BD4B-06197ECA1BB8 Q36320323-53A5926E-D03E-440D-ADD5-24211D5E8B03 Q36551840-F35E6C9C-2A7E-470E-BBFA-6F9D2146733E Q36640326-EDFC86DD-DD4D-42DA-B16D-9C53BFE697CE Q36771712-CC81D7F7-E9BC-4E5B-A5B0-F0B0A159E3CB Q37001778-365C4CDF-D963-4291-881D-FF4794E0D678 Q37069755-A99E7C92-228C-475B-A8BD-E9DDF1150DFD Q37522842-E795CD46-8D6F-4047-A3DA-ABAEF8BB5ED8 Q37628867-0E6E6E3B-1F7C-45A8-851E-3827F3E3FE07 Q37682917-5A4A4AA4-A6F3-4D9A-819F-59E868350EA6 Q37749719-3AF18749-6253-4DF0-A846-45FB5CFD887E Q37776723-778024F1-80C3-481B-A2F4-DFDF65EBFDC6 Q38971911-6A19DFC7-93C2-45E9-944B-0E9CCFC4D2EE Q39509403-AFE93B2B-4F87-46B7-923C-A3A5948CFC42 Q39522002-DAF599F0-FA27-4B69-933E-405A09C9236A Q39741614-1ADB47ED-AD49-417A-8330-13BF0753049D Q39971245-229E0332-DBED-4BE1-A6C8-20A6DC1CC020 Q40504212-8AEDA3AF-07FF-4148-A856-A5B402697646 Q40564857-799E5060-826C-4606-9DCB-7341680C7F24 Q40813264-B39B0D37-1985-401A-A203-59A5E97970D3

P2860

Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

http://www.wikidata.org/entity/Q37494112

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment of experimental auto ...... ed to cholera toxin B subunit.

@en

Treatment of experimental auto ...... ed to cholera toxin B subunit.

@nl

type

label

Treatment of experimental auto ...... ed to cholera toxin B subunit.

@en

Treatment of experimental auto ...... ed to cholera toxin B subunit.

@nl

prefLabel

Treatment of experimental auto ...... ed to cholera toxin B subunit.

@en

Treatment of experimental auto ...... ed to cholera toxin B subunit.

@nl

P1433

Q37494112-7D7DC83C-7875-4223-9A4A-B324A53639D8

P1476

Q37494112-73EB01C0-0173-4F40-8DEF-83FEB73DAB67

P2093

Q37494112-07C11E7F-D59F-41D4-8297-6B7DF68EB436

Q37494112-94B07CC9-9652-4B61-80F3-B2A0C93E7FE7

Q37494112-AC51EF93-63F8-42F1-8131-6815B79CE565

Q37494112-CB5D475C-2F13-4687-9ABF-8B8C8C00DF20

P2860

Q37494112-034DE002-FA20-48B0-A367-9683AF4DB7E4

Q37494112-04C20EF0-6565-4348-8B7A-A3855B0F4D9D

Q37494112-0C5CB521-27CA-4367-A196-1AEA5209342D

Q37494112-1A917EA9-F0AA-4483-867C-BC0CC9E8B060

Q37494112-1B6C0CB1-FC78-484F-8760-DF21EF9A4B55

Q37494112-2242C295-02A6-4C8F-BEFC-CBC69D1A7D47

Q37494112-2C000941-DEB1-4A22-97C6-56CC0E991EA0

Q37494112-2FB06884-58E1-48A4-B724-24ED93AB8A88

Q37494112-31396155-BCFD-4E54-8E00-ABFECB199D2C

Q37494112-35E57E7C-2960-4EF2-9AAF-03D825663008

P304

Q37494112-CE541BA2-8624-4355-94AC-BC42258FDE00

P31

Q37494112-B9A5D784-BB11-48B3-9CAE-29E455BF1FF2

P356

Q37494112-D3CECFE6-77DD-4C14-B7EB-8D79CABCE531

P407

Q37494112-9409A074-EE43-4969-8AC7-42436E89FDB8

P433

Q37494112-88033158-8FD8-41E5-AC88-8175E1BA1533

P478

Q37494112-F6FB0133-B0F2-4002-8A38-3C8F17496396

P50

Q37494112-18E1D6F9-E666-40CA-946C-8B900313F9B3

P577

Q37494112-1A13679F-14DE-47EE-A57D-0F9FBADFFA9E

P5875

Q37494112-FADE3B58-9A40-4D1D-8FD4-C1BEF3804783

P698

Q37494112-05B77811-7503-4498-997D-18372665B4ED

P921

Q37494112-465F64B6-C2CA-4FA0-AD7E-B26104ABCF7D

Q37494112-FA41215E-2FF9-4A66-8ECE-D019FF514137

P932

Q37494112-2BA92A04-CA2C-4B5A-BA7B-E616103DF5EE

P356

PNAS.93.14.7196

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Treatment of experimental auto ...... ed to cholera toxin B subunit.

@en

P2093

Czerkinsky C

http://www.w3.org/2001/XMLSchema#string

Olsson T

http://www.w3.org/2001/XMLSchema#string

Rask C

http://www.w3.org/2001/XMLSchema#string

Sun JB

http://www.w3.org/2001/XMLSchema#string

P2860

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Specific T-cell tolerance may reflect selective activation of lymphokine synthesis.

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.

Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

P304

7196-7201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.93.14.7196

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P50

P577

1996-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14509225

http://www.w3.org/2001/XMLSchema#string

P698

8692968

http://www.w3.org/2001/XMLSchema#string

P921

experimental autoimmune encephalomyelitis

P932

38959

http://www.w3.org/2001/XMLSchema#string